GlassScriptPhysician profile
Adam M Levine
NPI 1528267887
$64,204.44
in general payments reported to CMS, 2019-2025
50 companies · $8,875 in 2025
The $8,875 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $5,247 · 2021: $5,338 · 2022: $10K · 2023: $8,486 · 2024: $15K · 2025: $8,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,750.00 |
| Food and Beverage | $11,241.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37,128.94 | 2019-2025 | Lifevest |
| Abbott Laboratories | $12,959.37 | 2019-2025 | Aveir, Cardiomems, Perclose Prostyle |
| Inari Medical, INC. | $1,219.87 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $1,161.89 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $1,025.68 | 2019-2025 | General - Therapies, Watchman Flx, Emblem Mri S-Icd |
| Medtronic Vascular, INC. | $967.65 | 2019-2020 | |
| Shockwave Medical, INC | $946.53 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $882.27 | 2021-2025 | Onyx Frontier, Abre, Everflex |
| Amgen INC. | $802.44 | 2019-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $748.54 | 2019-2025 | Optimizer, Optimizer |
| Atricure, INC. | $713.92 | 2022-2024 | |
| Abiomed | $629.88 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $619.58 | 2019-2025 | Farxiga |
| Pfizer INC. | $581.23 | 2019-2025 | |
| Cardiovascular Systems INC. | $470.57 | 2019-2023 | Diamondback Peripheral |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.